OUR SOLUTION
Introducing Percutaneous Synchronized Cardiac Assist (PSCA)
A novel extravascular, intrapericardial device that provides ventricular augmentation without the need for vascular access or systemic anticoagulation.
Human clinical studies are currently underway to assess the preliminary safety, feasibility, and hemodynamic performance of the PSCA System in patients with cardiogenic shock. Results to-date have been presented at multiple, major cardiology conferences. Read more here.
How it works
Highly differentiated technology
This novel implant and its extravascular placement (using a simple, less invasive procedure) is designed to avoid many of the risks and complications of current, temporary MCS devices
Extravascular/extracardiac
Less invasive and avoids hemolysis, stroke
No contrast imaging
Reduces contrast-induced nephropathy
No anticoagulants
